Bionic Sight’s BS01 Gene Therapy Receives RMAT Designation from the FDA
Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP)NEW YORK, Feb. 18, 2025 ...
Business Insider9 天
Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT ...
A regenerative medicine therapy is eligible for RMAT designation if it is intended to treat ... EXG-34217 is a dose of autologous CD34 + HSCs that have transiently expressed Zinc finger and SCAN ...